Advertisement

Topics

Dragonfly Therapeutics names world leader in NK therapeutics as CSO

07:58 EDT 27 Jun 2017 | thePharmaLetter

Dragonfly Therapeutics has appointed Nicolai Wagtmann as its chief scientific officer (CSO).

Original Article: Dragonfly Therapeutics names world leader in NK therapeutics as CSO

NEXT ARTICLE

More From BioPortfolio on "Dragonfly Therapeutics names world leader in NK therapeutics as CSO"

Quick Search
Advertisement